NIDDK High-Risk Multi-Center Clinical Studies
National Institutes of Health
Description
The NIDDK offers support for high-risk, multi-center clinical studies through a two-step process that includes an initial implementation planning phase (U34). The U34 phase allows for early peer review of the study's rationale, assessment of its design, and development of necessary study documents and other essential elements. The study should be hypothesis-driven and related to a disease within NIDDK's mission. Applicants are encouraged to consult with NIDDK scientific staff before submitti…
NIDDK supports investigator-initiated, high-risk multi-center (more than one center) clinical studies through a two-part process that may include an implementation planning cooperative agreement (U34). The U34 is designed to: 1) Permit early peer review of the rationale for the proposed clinical…
Source
Grant ID
PAR-25-090
Agency
National Institutes of Health
Subcategory/Subagency
National Institute of Diabetes and Digestive and Kidney Diseases
Key Dates
Opportunity Released
January 10, 2025
Eligibility
The following categories of applicants are invited to apply:
- County Governments
- City or Township Governments
- Special District Governments
- Indian/Native American Tribal Governments (Federally Recognized)
- Indian/Native American Tribal Governments (Other than Federally Recognized)
- Eligible Agencies of the Federal Government
- U.S. Territory or Possession
- Independent School Districts
- Public Housing Authorities/Indian Housing Authorities
- Native American Tribal Organizations (other than Federally recognized tribal governments)
- Faith-based or Community-based Organizations
- Regional Organizations
- Higher Education Institutions (Public/State-Controlled Institutions of Higher Education)
- Higher Education Institutions (Private Institutions of Higher Education)
- Nonprofit Organizations with 501(c)(3) status (other than Institutions of Higher Education)
- Nonprofit Organizations without 501(c)(3) status (other than Institutions of Higher Education)
- For-Profit Organizations (Small Businesses)
- For-Profit Organizations (Other than Small Businesses)
- Local Governments
- State Governments
Awards & Funding
Award Ceiling
$225,000
Funding Amount
~$225,000
Similar opportunities
- Investigator-Initiated High-Risk Multi-Center Clinical Trials
National Institutes of Health
- Funding Opportunity Purpose
National Institutes of Health
- Small R01s for Clinical Trials Targeting Diseases within the Mission of NIDDK (R01 Clinical Trial Required)
National Institutes of Health
- Small R01s for Clinical Trials Targeting Diseases within the Mission of NIDDK (R01 Clinical Trial Required)
National Institutes of Health
- Leveraging NICHD Clinical Research Network Infrastructure for Innovative Clinical Trials and Observational Studies
National Institutes of Health